EVENTS


6th NASH Roundtable™ Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?

More information »

5th NASH Roundtable™ Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?

More information »

RESOURCES


Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »

MEMBER CO-AUTHORED PUBLICATIONS


March, 2023

Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Read More »

March, 2023

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Read More »

March, 2023

Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Read More »

March, 2023

Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials. Read More »